Atreca
Signal active
Organization
Contact Information
Overview
Atreca is a biopharmaceutical that develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen. Its product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target-derived from an antibody identified using its discovery platform.
About
Industries
Biotechnology, Health Care, Therapeutics, Product Research
Founded
2010
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Atreca headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics, Product Research sector. The company focuses on Biotechnology and has secured $39.0B in funding across 112 round(s). With a team of 51-100 employees, Atreca is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Atreca, raised $6.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
7
Investors
2
Lead Investors
0
Total Funding Amount
$347.9M
Details
3
Atreca has raised a total of $347.9M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Late Stage Venture | 125.0M | ||
| 2017 | Early Stage Venture | 35.0M | ||
| 2015 | Early Stage Venture | 56.0M |
Investors
Atreca is funded by 23 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Atreca | - | FUNDING ROUND - Atreca | 6.0M |
| Bill & Melinda Gates Foundation | - | FUNDING ROUND - Bill & Melinda Gates Foundation | 6.0M |
| Atreca | - | FUNDING ROUND - Atreca | 6.0M |
| Ling Wong | - | FUNDING ROUND - Ling Wong | 6.0M |
Recent Activity
There is no recent news or activity for this profile.